Pharmaceutical Market Europe • June 2026 • 5

CONTENTS

June 2026

NEWS & COLUMNS


6-7 NEWS
GSK acquires Nuvalent for $10.6bn;
Pfizer and Innovent agree on $10.5bn deal

8-9 NEWS
Lilly to buy three companies in $3.83bn deals; Novo’s Wegovy weight loss pill approved in UK

11 DERMATOLOGY NEWS
Alnylam and Inceptive in $2bn AI deal;
LEO and Allergy UK launch CHE campaign

12 DARWIN’S MEDICINE
Evolution explains successful branding

13 SURFING THE AI WAVE
Acquiring the ‘senior’ skill set more quickly

14 AI PHARMA BRAND PLANNING
As AI moves beyond analysis and task support

15 LISTENING, LANGUAGE AND LOCATION
The power of healthcare comms in women’s health

FEATURES


16-18 ASCO 2026 – THE ART OF TRANSLATION
Translating emerging science into care that works meaningfully in practice: ASCO 2026 wasn't just about hazard ratios and first-in-class molecules, but about how we translate scientific progress into better outcomes for patients

20-21 THE UK LIFE SCIENCES’ CROSSROADS – DEFINED BY SPEED, SCALE AND INVESTMENT
The UK’s challenge is less about capability and more about how global pharma now operates. Pharmaceutical companies are allocating capital based on where they can achieve the strongest and most sustainable return

26-27 PMEA 2026 WELCOMES SIMON BATES AS NEW CHAIR OF THE JUDGING PANEL
The PMEAs, with a team of over 20 judges from different companies, healthcare organisations, academia and charities, celebrate excellence within the pharmaceutical, biotech and medtech sectors

COMMUNIQUE
MARKETING & COMMS


28-29 STEERING GENERATIVE AI INTO THE PHARMA FAST LANE
GenAI is flourishing across drug discovery, clinical trials and healthcare system recalibration, but many fear its potential power is dissipating through a lack of co-ordinated application across departments

30-32 LAUNCHING INTO AN AI-POWERED FUTURE: A PRESCRIPTION FOR SUCCESS
Making launch more precise, cost-effective and agile demands new thinking and new technologies. Pharma companies are launching more innovative products while facing faster, fiercer competition

33-35 AAA LAUNCH EXCELLENCE – AGILE, ADAPTIVE AND AGENTIC
Over time, the use of AI agents will support a broader range of launch processes and workflows, enabling teams to move faster, make more informed decisions and operate with greater efficiency

CAREERS & RECRUITMENT


36-37 APPOINTMENTS
Each month, we bring you the latest news on job changes in the pharma sector. This month, we are highlighting change at Pfizer, Gates Medical Research Institute and Moderna

0